Your browser doesn't support javascript.
loading
Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models.
Carvalho, Mariana R; Lima, Daniela; Reis, Rui L; Oliveira, Joaquim M; Correlo, Vitor M.
Afiliação
  • Carvalho MR; 3B's Research Group - Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, AvePark, 4806-909 Taipas, Guimarães, Portugal.
  • Lima D; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Reis RL; 3B's Research Group - Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, AvePark, 4806-909 Taipas, Guimarães, Portugal.
  • Oliveira JM; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
  • Correlo VM; 3B's Research Group - Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, AvePark, 4806-909 Taipas, Guimarães, Portugal. rgreis@dep.uminho.pt.
Stem Cell Rev Rep ; 13(3): 347-363, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28233276

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios de Seleção de Medicamentos Antitumorais / Engenharia Tecidual / Modelos Biológicos / Neoplasias / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios de Seleção de Medicamentos Antitumorais / Engenharia Tecidual / Modelos Biológicos / Neoplasias / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article